The Astellas Global Health Foundation is an international philanthropic organization dedicated to making a sustainable impact on the health of people around the world and building toward “One World, A Healthier Tomorrow.” Launched in November 2018, the Astellas Global Health Foundation supports initiatives in the most underserved communities within low- and middle-income countries where Astellas does not have a business presence.
Our specific areas of focus include:
In 2017, the World Health Organization (WHO) made a bold commitment: WHO and like-minded organizations will work to reach zero deaths from avoidable deaths due to diseases. The Astellas Global Health Foundation joins this mission to end epidemics for the most neglected among us by the year 2030. Join us in building One World, A Healthier Tomorrow.
*The Astellas Global Health Foundation merged three Astellas philanthropic entities in November 2018 – the Astellas USA Foundation (AUSF), the Astellas European Foundation (AEF), and the Astellas Asia-Oceanic Foundation (AAOF) into one organization.
The Astellas Global Health Foundation seeks to address the challenges of improving access to health, building resilient communities, and providing disaster relief for significantly underserved communities in low- and middle-income countries where Astellas does not have a business presence.
Partnering with organizations like the END Fund to improve access to treatment for neglected tropical diseases (NTDs) in support of WHO goals for control and elimination of NTDs in low-income populations.
The Astellas Global Health Foundation contributed $750,000 to the END Fund in 2019 to combat neglected tropical diseases in the Democratic Republic of Congo. This investment from the Foundation will enable the END Fund to increase its programming designed to control and eliminate neglected tropical diseases in a country faced with one of the highest burdens of NTDs in the world.
The Astellas Global Health Foundation also aims to combat communicable diseases (e.g., HIV/AIDS, tuberculosis and malaria) that are prevalent in developing countries and low-income populations. Stay tuned for additional funding updates.
100% OF LOW-INCOME COUNTRIES ARE AFFECTED BY AT LEAST FIVE NEGLECTED TROPICAL DISEASES SIMULTANEOUSLY
WHO Infectious Diseases: www.who.int/topics/infectious_diseases/en/
75% of those affected by mental, neurological
and substance use disorders in many
low-income countries do not have access to
the treatment they need
WHO Mental Health Gap Action Programme (mhGAP):
Improving access to mental health for low-income patients and caregivers in low- and middle-income countries, addressing the lack of proper diagnosis and treatment of mental illness and related conditions.
With the growing prevalence of mental illness among some of the most vulnerable populations, the Foundation seeks to address the lack of proper diagnosis and treatment of mental illness which can occur co-morbidly. The Foundation recently provided a $1.35 million grant over three years to the Academic Model Providing Access to Healthcare (AMPATH), a partnership of Kenyan and North American academic health centers, to support 400,000 people with mental health support in western Kenya. AMPATH will integrate mental health services into AMPATH’s chronic disease system in public health facilities and broaden population engagement through a mental health awareness campaign. Additionally, AMPATH will provide group transitional housing and care for patients with severe mental health disorders.
Providing grants to organizations that, for example, help improve access to medicines, nutrition, vaccines and other measures to children in need.
Through its support, the Foundation seeks to have long-term impact on the health of children given the high child mortality rates in low- and middle-income communities. Stay tuned for funding updates.
Access to simple, affordable interventions
could have saved the lives of more than
3.1 million children in 2017
WHO Factsheet: Children: reducing mortality www.who.int/news-room/